Maravai LifeSciences (MRVI) Competitors $5.22 +0.26 (+5.24%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends MRVI vs. AXSM, BHVN, ALKS, BBIO, RARE, PBH, OGN, PRGO, RYTM, and APLSShould you be buying Maravai LifeSciences stock or one of its competitors? The main competitors of Maravai LifeSciences include Axsome Therapeutics (AXSM), Biohaven (BHVN), Alkermes (ALKS), BridgeBio Pharma (BBIO), Ultragenyx Pharmaceutical (RARE), Prestige Consumer Healthcare (PBH), Organon & Co. (OGN), Perrigo (PRGO), Rhythm Pharmaceuticals (RYTM), and Apellis Pharmaceuticals (APLS). These companies are all part of the "pharmaceutical preparations" industry. Maravai LifeSciences vs. Axsome Therapeutics Biohaven Alkermes BridgeBio Pharma Ultragenyx Pharmaceutical Prestige Consumer Healthcare Organon & Co. Perrigo Rhythm Pharmaceuticals Apellis Pharmaceuticals Maravai LifeSciences (NASDAQ:MRVI) and Axsome Therapeutics (NASDAQ:AXSM) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, media sentiment, earnings, community ranking, dividends and institutional ownership. Is MRVI or AXSM more profitable? Maravai LifeSciences has a net margin of -81.13% compared to Axsome Therapeutics' net margin of -91.87%. Maravai LifeSciences' return on equity of -6.61% beat Axsome Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Maravai LifeSciences-81.13% -6.61% -3.45% Axsome Therapeutics -91.87%-158.36%-37.46% Which has more volatility and risk, MRVI or AXSM? Maravai LifeSciences has a beta of 0.02, meaning that its stock price is 98% less volatile than the S&P 500. Comparatively, Axsome Therapeutics has a beta of 1.26, meaning that its stock price is 26% more volatile than the S&P 500. Which has better earnings & valuation, MRVI or AXSM? Maravai LifeSciences has higher revenue and earnings than Axsome Therapeutics. Axsome Therapeutics is trading at a lower price-to-earnings ratio than Maravai LifeSciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMaravai LifeSciences$288.95M4.56-$119.03M-$1.64-3.18Axsome Therapeutics$270.60M17.67-$239.24M-$6.53-15.11 Does the MarketBeat Community believe in MRVI or AXSM? Axsome Therapeutics received 381 more outperform votes than Maravai LifeSciences when rated by MarketBeat users. Likewise, 69.00% of users gave Axsome Therapeutics an outperform vote while only 63.92% of users gave Maravai LifeSciences an outperform vote. CompanyUnderperformOutperformMaravai LifeSciencesOutperform Votes6263.92% Underperform Votes3536.08% Axsome TherapeuticsOutperform Votes44369.00% Underperform Votes19931.00% Do analysts prefer MRVI or AXSM? Maravai LifeSciences presently has a consensus price target of $10.33, indicating a potential upside of 97.96%. Axsome Therapeutics has a consensus price target of $124.93, indicating a potential upside of 26.60%. Given Maravai LifeSciences' higher probable upside, equities analysts plainly believe Maravai LifeSciences is more favorable than Axsome Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Maravai LifeSciences 0 Sell rating(s) 5 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.55Axsome Therapeutics 0 Sell rating(s) 0 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor MRVI or AXSM? In the previous week, Axsome Therapeutics had 4 more articles in the media than Maravai LifeSciences. MarketBeat recorded 8 mentions for Axsome Therapeutics and 4 mentions for Maravai LifeSciences. Axsome Therapeutics' average media sentiment score of 0.31 beat Maravai LifeSciences' score of 0.28 indicating that Axsome Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Maravai LifeSciences 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Axsome Therapeutics 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals and insiders hold more shares of MRVI or AXSM? 50.3% of Maravai LifeSciences shares are held by institutional investors. Comparatively, 81.5% of Axsome Therapeutics shares are held by institutional investors. 0.6% of Maravai LifeSciences shares are held by company insiders. Comparatively, 22.4% of Axsome Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. SummaryAxsome Therapeutics beats Maravai LifeSciences on 10 of the 18 factors compared between the two stocks. Ad Chaikin Analytics50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies. You can watch for it for free, right here. Get Maravai LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MRVI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MRVI vs. The Competition Export to ExcelMetricMaravai LifeSciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.32B$6.60B$5.21B$8.85BDividend YieldN/A8.14%5.53%4.08%P/E Ratio-3.185.9576.3614.80Price / Sales4.56357.081,247.6587.32Price / Cash52.3753.8240.9036.92Price / Book2.1510.617.196.55Net Income-$119.03M$153.27M$119.54M$226.22M7 Day Performance18.10%3.97%2.12%3.77%1 Month Performance-29.17%-6.72%-2.43%4.64%1 Year Performance0.97%33.26%34.51%29.21% Maravai LifeSciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MRVIMaravai LifeSciences4.7787 of 5 stars$5.22+5.2%$10.33+98.0%+1.0%$1.32B$276.92M-3.18580AXSMAxsome Therapeutics4.6241 of 5 stars$98.19+3.8%$124.93+27.2%+64.2%$4.76B$270.60M-14.49589Analyst UpgradeBHVNBiohaven3.9155 of 5 stars$45.19-3.5%$63.42+40.3%+50.7%$4.57B$462.51M-4.83239Positive NewsALKSAlkermes4.5744 of 5 stars$27.79-0.4%$35.42+27.4%+18.0%$4.50B$1.66B14.252,100Positive NewsBBIOBridgeBio Pharma4.5995 of 5 stars$23.24+0.9%$47.57+104.7%-20.6%$4.39B$9.30M-9.64400Insider TradeNews CoverageRAREUltragenyx Pharmaceutical4.6634 of 5 stars$46.02-0.8%$87.46+90.1%+23.6%$4.28B$522.75M-7.111,276Analyst ForecastPBHPrestige Consumer Healthcare3.474 of 5 stars$84.09+1.7%$83.67-0.5%+45.6%$4.15B$1.11B20.46540Insider TradeOGNOrganon & Co.4.7498 of 5 stars$14.91+1.2%$21.33+43.1%+35.9%$3.84B$6.26B2.9610,000PRGOPerrigo4.983 of 5 stars$27.10-0.2%$37.00+36.5%-7.8%$3.70B$4.66B-23.169,140Positive NewsRYTMRhythm Pharmaceuticals3.1746 of 5 stars$59.27-0.2%$62.30+5.1%+78.8%$3.64B$77.43M-13.69140Analyst ForecastAPLSApellis Pharmaceuticals4.6356 of 5 stars$28.01+1.9%$49.94+78.3%-35.4%$3.48B$396.59M-13.80702Analyst ForecastNews Coverage Related Companies and Tools Related Companies AXSM Alternatives BHVN Alternatives ALKS Alternatives BBIO Alternatives RARE Alternatives PBH Alternatives OGN Alternatives PRGO Alternatives RYTM Alternatives APLS Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MRVI) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Maravai LifeSciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Maravai LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
